N/A
Completed N=90
A Clinical Study of the Effectiveness and Safety of a Disposable Intra-vaginal Device for Stress Urinary Incontinence (SUI)
Stress Urinary Incontinence (SUI)
Source: ClinicalTrials.gov NCT02131311 ↗
Enrolled (actual)
90
Serious AEs
0.0%
Results posted
Mar 2016
Primary outcomePrimary: Percentage of Responders for Pad Weight Gain or SUI Episodes — 69 percentage of subjects
Summary
This study will evaluate the effectiveness of the pessary device by assessing reduction in urine leakage in approximately 80 women with SUI. Efficacy will be assessed by pad weight gain, frequency of stress urinary incontinence events, and a quality of life questionnaire.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Responders for Pad Weight Gain or SUI Episodes |
67 | — |
| SECONDARY Change in Stress Urinary Incontinence Episodes |
1.3 | — |
| SECONDARY Change in Pad Weight Gain |
4.68 | — |
| SECONDARY Change in Quality of Life as Measured by Incontinence Impact Questionnaire (IIQ-7) |
24 | — |
| SECONDARY Percentage of Responders for Pad Weight Gain or SUI Episodes |
67 | — |
Eligibility Criteria
Inclusion Criteria
- be female 18 years or older;
- provide written informed consent prior to study participation and receive a signed copy;
- be in generally good health as determined by the Investigator;
- have a ≥ 3 month history of experiencing SUI (self reported);
- be willing to use the pessary investigational device to control stress urinary incontinence;
- be willing to comply with study requirements and instructions;
Exclusion Criteria
- pregnant, lactating or planning to become pregnant during the study;
- within 3 months post partum;
- intrauterine device (IUD) placement of less than 6 months;
- has self-reported difficulty emptying her bladder;
- a history of Toxic Shock Syndrome (TSS) or symptoms consistent with TSS;
- experience difficulty inserting or wearing an intra-vaginal device, including a tampon;
- vaginal surgery, perineal surgery, uterine surgery, or abortion (spontaneous or induced) within the past 3 months;
- has any Screening laboratory value outside the laboratory reference range considered clinically significant by the Investigator which could impact the safety of the subject or the outcome of the study;
- for any reason, the Investigator decides that the subject should not participate in the study.
Data sourced from ClinicalTrials.gov (NCT02131311). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.